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Abstract 
During embryogenesis, the mammalian
heart develops from a primitive heart tube
originating from two bilateral primary heart
fields located in the lateral plate mesoderm.
Cells belongings to the pre-cardiac mesoderm
will differentiate into early cardiac progeni-
tors, which express early transcription factors
which are also common to the Isl-1 positive
cardiac progenitor cells isolated from the
developing pharyngeal mesoderm and the
foetal and post-natal mice hearts. A second
population of cardiac progenitor cells positive
to c-Kit has been abundantly isolated from
adult hearts. Until now, these two populations
have been considered two different sets of pro-
genitor cells present in the heart in different
stages of an individual life. In the present
study we collected embryonic, foetal and infant
hearts, and we tested the hypotheses that c-Kit
positive cells, usually isolated from the adult
heart, are also present in the intra-uterine life
and persist in the adult heart after birth, and
that  foetal Isl-1 positive cells are also positive
to c-Kit. Using immunohistochemistry we
studied the temporal distribution of Isl-1 posi-
tive and c-Kit/CD105 double positive cells, and
by immunofluorescence and confocal analysis
we studied the co-localization of c-Kit and Isl-1
positive cells. The results indicated that car-
diomyocytes and interstitial cells were positive
for c-Kit from the 9th to the 19h gestational
week, that cells positive for both c-Kit and
CD105 appeared in the interstitium at the 17h
gestational week and persisted in the postnatal
age, and that the Isl-1 positive cells were a sub-
set of the c-Kit positive population. 
Introduction
The mechanisms involved in establishing
the early heart and regulating its morphogene-
sis have been widely studied.1 During embryo-
genesis, the atrioventricular (A-V) canal and
the sinu-atrial segment at the venous pole as
well as the conotruncus at the arterial pole are
added to the heart tube during tube looping.2,3
Most of the cells that will differentiate into the
developing myocardium are derived from a
population of progenitor cells located in the
pharyngeal mesoderm, termed the secondary
heart field (SHF).4-6
Cells belongings to the pre-cardiac meso-
derm will differentiate into early cardiac pro-
genitors which can in turn differentiate into
primitive cardiomyocytes, smooth muscle cells
and endothelial cells.7 Known markers of pre-
cardiac cells of the primary and the secondary
heart field are Nkx2.5 and GATA-4.4 The
expression of these two transcription factors is
common to the LIM homeobox transcription
factor positive (Isl-1+) cardiac progenitor cells
(CPCs) and the developing pharyngeal meso-
derm8 as well as foetal and post-natal mice
hearts.9 This small number of Isl-1+ cells has
been identified as a residue of the migrating
SHF cells and may be considered resident pro-
genitor cells in the myocardium in the post-
natal age.10
With regard to the Isl-1+ cell distribution,
Genead et al.11 described the frequency of Isl-
1+ cells in the early first trimester human
embryonic heart. They did not observe differ-
ences among the outflow tract, atria and right
ventricle, confirming what had been previous-
ly reported for the late first and early second
trimester.12 Clusters of Isl-1+ cells were identi-
fied in the right atrial wall of foetal and new
born hearts, whereas occasional Isl-1+ cells
have been found in the ventricular regions.13
Isl-1 has been identified as a marker of CPCs
in the adult rat heart,14,15 giving support to the
hypothesis that some cells from the embryo
may also persist into adulthood.16
Most studies concerning the localisation of
CPCs in the developing heart have been per-
formed in mice or chicks. The localisation and
identification of CPCs in the human foetal and
adult heart has been investigated for the first
time by Limana and colleagues,17 with their
analysis limited to epicardium and CD34+ or c-
Kit+ cells. Cells expressing c-Kit were identi-
fied also in the human foetal and post-natal
myocardium specimens. These cells were
located within the connective tissue and with-
in muscle bundles. Their number declined over
time until the first post-natal month.18
The transmembrane receptor tyrosine kinase
c-Kit is expressed on the cell surface of stem
cells during haematopoiesis,19 dental pulp stem
cells originating from the neural crest cells,20 in
the developing pancreas,21 and recently as been
proposed as a useful marker to differentiate pri-
mary melanoma from compound nevi.22 Apart
from the many studies on the expression and
localization of this receptor, c-Kit has been pro-
posed also as the most important marker for
adult CPCs.23,24 The first isolation and character-
isation of adult human CPCs has been per-
formed from percutaneous right ventricular
endocardial biopsy specimens by Smith and col-
leagues.25 Multipotent CPCs from human car-
diospheres consistently expressed c-Kit and
CD105, the regulatory component of the trans-
forming growth factor-b receptor complex that is
important in angiogenesis26 and haemato -
poiesis.27 Therefore, it seems that c-Kit+ cells are
CPCs homing the myocardium in the adulthood,
while Isl-1+ cells have been proposed as a differ-
ent subset of undifferentiated cells able to gen-
erate endothelial cells, cardiomyocytes, smooth
muscle cells and cardiac fibroblasts but present
only in the developing heart and persisting in
the post-natal age.8,28,29 In the mean time anoth-
er subset of cardiac undifferentiated cells (epi-
cardial progenitors) has been identified which
barely participate in atria, right ventricle and
outflow tract formation and that are detectable
in the murine and human foetal, but not adult
hearts.30 In the present study, we analysed
human hearts from embryos, foetuses and
neonates at different gestational ages to deter-
mine the presence and co-localization of the Isl-
1+ CPCs identified in the embryonic and post-
natal heart, and the c-Kit+/CD105+ cells
described in the adult heart, to understand if the
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c-Kit+ cells abundantly isolated from adult hearts
are present also in the embryonic and foetal
heart and if they are a different subset of the
extensively studied Isl-1+ cells. 
Materials and MethodsHuman cardiac samples
Cardiac tissue samples, comprising the
endocardial, myocardial, and epicardial layers
of the ventricles, were obtained by autopsy
from embryos, foetuses, preterm infants, and
term infants and collected, after written con-
sent from the mother, in the Department of
Human Pathology of the University of Messina,
Italy. The procedures followed were in accor-
dance with the ethical standards of the respon-
sible committee on human experimentation
and with the Helsinki Declaration of 1975. The
Ethics Committee of the University of Messina
approved the study.
Gestational age of the foetuses ranged
between 9 and 40 weeks, as shown in Table 1
and Table 2. Specifically, our cohort comprised
25 samples. The causes related to the death of
the analysed foetuses and of the preterm and
term infants are shown in Table 1 and Table 2.
Autopsies and sample collections were carried
out immediately after delivery with less than a
24-hour interval since foetal death had
occurred.
All samples were fixed in 10% formalin and
embedded in paraffin for morphological diag-
nostic evaluation (haematoxylin/eosin) and
immunohistochemistry. 
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Table 1. Clinical and morphological data and c-Kit/CD105 expression in 1 embryo, 12 foetuses, 1 preterm infant and 1 term infant.
Case No. Trimester Gestational Age at Cause of Heart Cardiomyocytes Endocardium Intestitial 
age (wks) death death malformations cells
Embryo
1 I 9 9 wks VT Endocardial cushion c-Kit+ CD105+ c-Kit+/CD105
defect (AVC of the heart)
Foetuses
2 I 13 13 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
3 II 14 14 wks TA for CRS VSD c-Kit + CD105+ c-Kit+/CD105-
4 II 14 14 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
5 II 14 14 wks TA for cerebral malformations Absent c-Kit+ CD105+ c-Kit+/CD105-
6 II 15 15 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
7 II 16 16 wks SA for abruption placentae Absent c-Kit+ CD105+ c-Kit+/CD105-
8 II 17 17 wks TA for cerebral malformations Absent c-Kit+/- CD105+ c-Kit+/CD105+
9 II 18 18 wks TA for MCA Absent c-Kit+/- CD105+ c-Kit+/ CD105+
10 II 19 19 wks TA for PKD, UBH, CLGP left, PEV bilateral Absent c-Ki+/- CD105+ c-Kit +/CD105+
11 II 22 22 wks SA for chorioamnionitis Absent c-Kit+/- CD105+ c-Kit +/CD105+
12 II 22 22 wks SA for chorioamnionitis Absent c-Kit - CD105+ c-Kit +/CD105+
13 III 27 27 wks SA for abruption placentae Absent c-Kit - CD105+ c-Kit +/CD105+
Preterm infant
14 III 36 1 day Respiratory failure Absent c-Kit - CD105+ c-Kit +/CD105+
Term infant
15 III 40 6 yrs Disseminate intravascular coagulation Absent c-Kit - CD105+ c-Kit +/CD105+
TA, therapeutic abortion; SA, spontaneous abortion; CLGP, cheilo-gnatho-palatischisis; CRS, caudal regression syndrome; MCA, multiple congenital anomalies; PEV, pes equino varus; PDK, polycystic kidney disease. 
Table 2. Clinical and morphological data and number of Isl-1 positive cells per area (mm2) in 7 foetuses, 2 preterm infants and 1 term Infant. 
Case No. Trimester Gestational Age at Cause of Growth Heart Section area Isl-1+ cells/mm2 x 
age (wks) death death defects malformations (mm2) 104*
Foetuses
16 II 14 14 wks Abruptio placentae Absent Absent 56171.5±11561.46 4.523±1.22
17 II 15 15 wks TA for Prune-Belly Absent Absent 46063±3055.72 3.543±0.15
syndrome
18 II 16 16 wks TA for trisomy 21 IUGR Absent 83666.33±2011.76 1.394±0.17
19 II 19 19 wks TA for trisomy 21 Absent Absent 71642.66±4190.29 1.141±0.62
20 II 20 20 wks TA for trisomy 21 Absent Absent 186604.66±9018 0.735±0.10
21 II 21 21 wks TA for trisomy 21 Absent Absent 119550.33±4100.16 0.889±0.14
22 II 22 22 wks TA for cerebral Absent Absent 162438±7750.21 0.738±0.02
malformations
Preterm infants
23 III 26 8 days Respiratory failure IUGR Ventricular septal 101629±1409.49 1.279±0.08
hypertrophy
24 III 36 2 hrs Sepsis Absent Ventricular septal 165575.33±2524.22 0.664±0.05
hypertrophy
Term infants
25 III 40 8 hrs Respiratory failure Absent Absent 202609±13666.33 0.548±0.12
*Data for which a t-test for dependent samples was performed, P<0.05. Gestational weeks (independent variable); Isl-1+ cells/mm2 (dependent variable); TA,  therapeutic abortion; IUGR, intrauterin
growth retardation; UBH, urinary bladder hypoplasia; VSD, ventricular septal defect; VT, voluntary termination; +, strongly positive; +/-, weakly positive.
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Immunohistochemistry
Single immunohistochemistry was per-
formed by a streptavidin-biotin complex
method using LSAB2 kit (DAKO Co.,
Carpinteria, CA, USA). After deparaffination
and rehydration, the tissue sections were incu-
bated with the protein blocking agent (DAKO)
for 10 min and the primary antibody for 1 h. We
used the anti-Isl-1 antibody (1:200, rabbit poly-
clonal, AB5754, Chemicon Int., Millipore Corp.,
Billerica, MA). The linked primary antibody
was detected with DAKO LSAB2 streptavidin-
peroxidase system according to manufactur-
er’s instructions. 3-Amino-9-ethylcarbazole
(AEC) was used as a chromogen, whereas
hematoxylin was used as a light counterstain.
Double immunohistochemistry was per-
formed by a streptavidin-biotin complex for the
goat polyclonal antibody (CD105) and labelled
using polymer-alkalyne phosphatase (AP) for
the rabbit polyclonal antibody (c-Kit). After
deparaffination and rehydration the tissue
sections were incubated with the Peroxidase
Block solution (Vector Laboratories Inc.,
Burlingame, CA, USA) for 5 min, washed in
PBS for 5 min, and incubated with the anti-
CD105 goat polyclonal antibody (1:50, SC-
19793, Santa Cruz Biotechnology Inc., Santa
Cruz, CA) for 30 min. After washing in PBS,
sections were incubated with the biotinylated
anti-goat secondary antibody (1:200, SC-2774,
Santa Cruz Biotechnology Inc.) for 30 min, and
washed again in PBS. For the antibody detec-
tion the streptavidin-HRP complex (LSAB2 kit
DAKO) was used for 10 min. Sections were
then rinsed in PBS with 0.1% Tween 20 (T-
PBS) for 5 min, and incubated with 3,3’-
Diaminobenzidine (DAB – Vector
Laboratories) as the HRP-substrate.
After the detection of the first antigen, sec-
tions were incubated with the Doublestain
Block solution (Vector Laboratories) for 3 min,
washed in T-PBS for 5 min, and incubated with
the anti-c-Kit rabbit polyclonal antibody (1:200,
KAP-TK005, Stressgen Bioreagents, Ann Arbor,
MI, USA) for 30 min. After washing with T-PBS
for 5 min, sections were incubated with a
labelled polymer – AP secondary antibody
(Vector Laboratories) for 30 min, and washed
again. Fast red (Vector Laboratories) was used
as the AP substrate for 5 min. Sections were
then washed in tap water and counterstained
with hematoxylin for 1 min. DAKO Aqueous
mounting medium was used. Each tissue sec-
tion was analysed by two independent
observers (CS and PC) who evaluated the
number of positive cells in three paraffin
embedded sections independently stained.
To analyse the number of Isl-1 positive cells
the area of each section was determined. It
was taken a 100%-600dpi picture of each
stained slide using an Epson Perfection 1200
Scanner connected to a personal computer.
The section sizes were too big to be measured
with pictures taken at the microscope. Each
picture was then converted to an 8-bit picture,
Brightness was adjusted and Threshold
applied. On the Threshold pictures the Analyze
particles function of the ImageJ Software
(released by the NIH, http://rsbweb.nih.gov/ij/)
was applied to measure the area of the
coloured sections. Data are shown in Table 2.
An example of the area measurement is shown
in Appendix Figure 1.Immunofluorescence
After deparaffination and rehydration, tis-
sue sections were blocked with 5% BSA in PBS
for 30 min and incubated with the first primary
antibody overnight, one night for each anti-
body (1:50, anti-c-Kit, KAP-TK005, Stressgen
Bioreagents; 1:50, anti-Isl-1, goat polyclonal,
SC-23590, Santa Cruz Biotechnology Inc.).
After washing with PBS, cells were further
incubated with fluorescent secondary antibod-
ies 1 h at room temperature (1:50, TRITC-con-
jugated anti-rabbit secondary antibody, T5268,
Sigma-Aldrich, St. Louis, MO; 1:50 FITC-conju-
gated donkey anti-goat secondary antibody,
SC-2024, Santa Cruz Biotechnology Inc.). In
single immunofluorescence experiments
nuclei were stained 10 min with 10 μg/mL
Hoechst33342 staining in PBS (Invitrogen
Original paper
Figure 1. Identification of interstitial c-Kit+/CD105+ and Isl-1+ cells in human foetal and
infant hearts before (A-D) and after (E-G) the 17th gestational week. A, B, C)  c-Kit (Fast
Red) and CD105 (DAB) double immunostaining in a 16-week foetal heart. E, F)  c-Kit
(Fast Red) and CD105 (DAB) double immunostaining in a preterm infant (36 weeks of
gestation, E) and in a term infant (6-year-old child. F) Black arrows indicate double
stained cells. D) Isl-1 (AEC) single immunostaining in a 14-week foetal heart; red arrows
indicate Isl-1 positive cells. G) Isl-1 (AEC) single immunostaining in a 21-week foetal
heart. Double positive cells appeared deep red; red arrow indicate Isl-1 positive cells.
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Corp., Carlsbad, CA, USA). In confocal experi-
ments nuclei were stained 15 min with 1 μM
Toto-3 staining in PBS (T3604, Invitrogen
Corp.). To avoid cross-reactions, sections were
incubated with goat-anti-Isl-1 first and with
rabbit anti-c-Kit after, and with donkey anti-
goat first and goat anti-rabbit after, in four dif-
ferent incubations. 
To avoid autofluorescence of paraffin/forma-
lin embedded sections, the samples were incu-
bated in 0.1% Sudan Black in 70% ethanol for
5 min after nuclei staining.31 For imaging they
were both used a Zeiss LSM5 Exciter Laser
Scanning Confocal Microscope and a Leica
CTR5000 fluorescent microscope. During con-
focal microscope observations all parameters
for picture acquisition were kept the same and
automatically saved.Statistical analysis
Data are shown as mean values and the
standard deviation has been calculated. The
hypothesis that the number of Isl-1+ cells per
mm2 varied with the gestational age was test-
ed using a t-test of dependent samples
(P<0.05). The hypothesis that there was a lin-
ear correlation between the gestational age of
the foetuses and the number of Isl-1+ cells per
mm2 was tested using the Pearson coefficient
(P<0.05). For the statistical analysis it was
used the STATISTICA 6.0 software (StatSoft
Italia srl, Vigonza, Italy). 
Results Expression of c-Kit on the mem-brane of cardiomyocytes of foetalhearts
To study the localization of c-Kit+ CPCs pre-
viously isolated and characterized in the rat
adult heart by our research group,14 we per-
formed immunohistochemistry and immuno-
fluorescence experiments on heart samples
from embryonic and foetal human hearts. 
As shown in Table 1 and Figure 1 A-C, many
interstitial and subepicardial cells and all car-
diomyocytes were positive for c-Kit from the 9th
to the 17th week of gestation, and sometimes
also to the 22nd week.
The expression of c-Kit on the surface of
cardiomyocytes of the first and second gesta-
tional trimesters was confirmed by immuno-
fluorescence experiments (Figure 2 A, F). In
the only embryonic sample (9th gestational
week) some structures similar to the primor-
dial myocardium of the cardiac tube were
clearly positive to c-Kit (Figure 2 B-C). Later
on during gestation, clusters of c-Kit+ cells
were present (Figure 2 D).
Immunolocalisation of cardiac pro-genitor cells
In literature there have been clearly identi-
fied two main populations of cardiac progeni-
tor cells: human cells double positive for c-Kit
and CD105 in adult hearts by Smith et al.,25 and
cells positive for Isl-1 by Laugwitz et al.9 in the
developing heart. To localize separately the two
populations in the human foetal hearts we per-
formed a double immunostaining for c-Kit and
CD105, and a single immunostaining for Isl-1.
Results were summarised in Table 1 for c-
Kit/CD105 and Table 2 for Isl-1.  
Interstitial c-Kit+/CD105+ cells appeared at
the 17th gestational week and persisted after
birth, as shown in Table 1 and Figure 1 E-F.
These double positive cells were localised only
in the myocardium and were never localised
inside capillaries. Many dividing cells were
identified in the myocardium (Figure 1F).
There were no differences between normal
hearts and foetuses with heart malformations
(Table 1).
From the 9th to the 16th gestational week,
they were present only c-Kit+ (in the subepi-
cardial space, Figure 1A, and in the myocardi-
um, Figure 1C) or CD105+ cells (endocardium
and endothelium, Figure 1B). Isl-1+ cells were
present in the myocardium and in the suben-
docardium, with no differences between right
and left ventricles. Groups of Isl-1+ cells were
sometimes visible, with a number ranging
between 4.523±1.22¥104 at the 14th gestation-
al week and 0.548±0.12¥104 per mm2 in the
post-natal age (Table 2, Figure 1 D,G). The t-
test for dependent variables demonstrated that
the decrease in the number of Isl-1+ cells was
Original paper
Figure 2. Expression of c-Kit and Isl-1 in embryonic and foetal hearts. A) Expression of c-
Kit in a 16-week foetal heart. B, C)  Expression of c-Kit in a 9-week human embryo. D)
A cluster of c-Kit+ cells in a 15-week foetal heart. E) Co-localization of c-Kit+ and Isl-1+
cells in a 14-week foetal heart; white arrows indicate cells double positive for Isl-1 and c-
Kit. F) Confocal microscopy analysis of the expression of c-Kit and Isl-1 in the myocardi-
um of a 16-week foetal heart.
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significant and that this difference depended
on the gestational week. The number of Isl-1+
cells was higher between the 14th and the 16-
19th gestational weeks and it was almost the
same between the 20th gestational week and
the post-natal age. The Pearson coefficient
(r=0.5; P=0.14) demonstrated that there was
not a linear correlation between the gestation-
al week and the number of cells per mm2.Colocalization of c-Kit+/Isl-1+ cells
To study whether these markers were
labelling the same or a different cell popula-
tion, we evaluated the co-expression of c-Kit
and Isl-1. We found that all the interstitial and
subendocardial Isl-1+ cells were positive for c-
Kit (Figure 2E), while not all the cells positive
for c-Kit were Isl-1+ (Appendix Figure 2).
Cardiomyocytes were positive only for c-Kit
(Figure 2F). The co-localization of the expres-
sion of c-Kit and Isl-1 on the same cell was con-
firmed by confocal microscopy (Appendix
Figure 3).
Discussion
In this study we described the localization
and the temporal distribution of c-Kit+/CD105+
and Isl-1+ cells from the embryonic to the post-
natal heart, and we tested the hypothesis if c-
Kit+ cells abundantly isolated from adult hearts
were also present in the embryonic and foetal
heart and if they represented a subset of cells
different from the Isl-1+ cell population.
Cardiac precursors can be isolated from
adult and post-natal hearts,9,32 and are charac-
terized by several markers among which c-Kit
both in foetal17 and adult heart,16 Isl-1 in early
cardiogenesis,9,28 and CD105 in human
endomyocardial biopsy specimens.25
With regard to these three CPC markers, the
present study shows that Isl-1+ cells are pres-
ent in the human hearts in foetuses, preterm
infants and term infants, that their number
decreases with the gestational week particu-
larly after the 16-19th gestational week, and
that there is a difference in the temporal dis-
tribution of c-Kit+ cells. These data also show
that cardiomyocytes and some interstitial cells
are c-Kit+ from the 9th to the 16th-19th gestation-
al weeks, and that after this time period, only a
few interstitial cells express c-Kit. Interstitial
cells, which express both c-Kit and CD105 on
their surfaces, are present only from the 17th
week to the 6th year of age. The presence of c-
Kit+/CD105+ cells in the different stages of ges-
tation does not demonstrate that c-Kit+ cells
are resident cardiac cells. But the fact that
many structures in the embryonic heart and
foetal cardiomyocytes are positive to c-Kit in
the early weeks of gestation provides evidence
that c-Kit+ cells are present in the heart from
the early stages of cardiogenesis, and their
number decreases during gestation until the
postnatal age.
We also demonstrated that the interstitial
and subendocardial Isl-1+ cells are positive
also to c-Kit. The co-localization of the two CPC
markers let us suppose that Isl-1+ cells are a
subset of the c-Kit+ CPCs population usually
isolated and identified in the adult heart.
The hypothesis that c-Kit+ human CPCs are
more abundant in the early stages of gestation
and that their number decreases over time is
supported by a recent paper, where the authors
isolated and grown human CPCs from neonate
and infant specimens.33 The c-Kit+ cells that
the authors isolated and expanded were also
positive to Isl-1 in culture inside cardios-
pheres, supporting our hypothesis that the
postnatal Isl-1+ cells may be a subpopulation of
c-Kit+ human CPCs, which originate from the
embryonic pre-cardiac mesoderm and probably
persist in the adulthood.
In conclusion, we have demonstrated that
foetal cardiomyocytes are positive to c-Kit, and
that foetal Isl-1+ cells are a subset of foetal c-
Kit+ CPCs. A better understanding of the local-
isation and migration of CPCs during cardio-
genesis may be achieved using mouse or
zebrafish transgenic models.
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